Prelude Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$136K	Sell	14,457 -3,360	-19%	-$31.5K	0.01%	863
2025 Q1	$127K	Buy	+17,817	New	+$127K	0.01%	928
2021 Q3	–	Hold	0	–	–	–	1605
2021 Q2	–	Hold	0	–	–	–	1539